Effect of teriparatide use on bone mineral density and spinal fusion: A narrative review of animal models

Yagiz Yolcu, Mohammed Alvi, Nathan Wanderman, Bayard Carlson, Arjun Sebastian, Mohamad Bydon, Brett Freedman

Research output: Contribution to journalArticle

Abstract

Purpose of the study: Teriparatide (Human recombinant Parathyroid Hormone 1-34) is an anabolic agent that is frequently used in patients with osteoporosis and has been extensively investigated with animal model and clinical studies in current literature. The purpose of the study was to evaluate the impact of teriparatide on bone mineral density and fusion. Materials and methods: The findings from preclinical studies that have investigated the role of teriparatide in animal models are summarized in presented review. Results: Overall, the studies show an improvement in bone mineral density and increased fusion rates for osteoporotic animals undergoing spine fusion with teriparatide use. Conclusion: Further studies should be conducted for unanswered questions, such as teriparatide use before surgery, the effect on cervical fusion and surgery related complications.

Original languageEnglish (US)
Pages (from-to)814-820
Number of pages7
JournalInternational Journal of Neuroscience
Volume129
Issue number8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Teriparatide
Spinal Fusion
Bone Density
Animal Models
Anabolic Agents
Osteoporosis
Spine

Keywords

  • Animal model
  • Bmd
  • Lumbar fusion
  • Osteoporosis
  • Teriparatide

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effect of teriparatide use on bone mineral density and spinal fusion : A narrative review of animal models. / Yolcu, Yagiz; Alvi, Mohammed; Wanderman, Nathan; Carlson, Bayard; Sebastian, Arjun; Bydon, Mohamad; Freedman, Brett.

In: International Journal of Neuroscience, Vol. 129, No. 8, 01.01.2019, p. 814-820.

Research output: Contribution to journalArticle

Yolcu, Yagiz ; Alvi, Mohammed ; Wanderman, Nathan ; Carlson, Bayard ; Sebastian, Arjun ; Bydon, Mohamad ; Freedman, Brett. / Effect of teriparatide use on bone mineral density and spinal fusion : A narrative review of animal models. In: International Journal of Neuroscience. 2019 ; Vol. 129, No. 8. pp. 814-820.
@article{f34f31f5538e48a6a6592dbff3853935,
title = "Effect of teriparatide use on bone mineral density and spinal fusion: A narrative review of animal models",
abstract = "Purpose of the study: Teriparatide (Human recombinant Parathyroid Hormone 1-34) is an anabolic agent that is frequently used in patients with osteoporosis and has been extensively investigated with animal model and clinical studies in current literature. The purpose of the study was to evaluate the impact of teriparatide on bone mineral density and fusion. Materials and methods: The findings from preclinical studies that have investigated the role of teriparatide in animal models are summarized in presented review. Results: Overall, the studies show an improvement in bone mineral density and increased fusion rates for osteoporotic animals undergoing spine fusion with teriparatide use. Conclusion: Further studies should be conducted for unanswered questions, such as teriparatide use before surgery, the effect on cervical fusion and surgery related complications.",
keywords = "Animal model, Bmd, Lumbar fusion, Osteoporosis, Teriparatide",
author = "Yagiz Yolcu and Mohammed Alvi and Nathan Wanderman and Bayard Carlson and Arjun Sebastian and Mohamad Bydon and Brett Freedman",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/00207454.2018.1564051",
language = "English (US)",
volume = "129",
pages = "814--820",
journal = "International Journal of Neuroscience",
issn = "0020-7454",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Effect of teriparatide use on bone mineral density and spinal fusion

T2 - A narrative review of animal models

AU - Yolcu, Yagiz

AU - Alvi, Mohammed

AU - Wanderman, Nathan

AU - Carlson, Bayard

AU - Sebastian, Arjun

AU - Bydon, Mohamad

AU - Freedman, Brett

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose of the study: Teriparatide (Human recombinant Parathyroid Hormone 1-34) is an anabolic agent that is frequently used in patients with osteoporosis and has been extensively investigated with animal model and clinical studies in current literature. The purpose of the study was to evaluate the impact of teriparatide on bone mineral density and fusion. Materials and methods: The findings from preclinical studies that have investigated the role of teriparatide in animal models are summarized in presented review. Results: Overall, the studies show an improvement in bone mineral density and increased fusion rates for osteoporotic animals undergoing spine fusion with teriparatide use. Conclusion: Further studies should be conducted for unanswered questions, such as teriparatide use before surgery, the effect on cervical fusion and surgery related complications.

AB - Purpose of the study: Teriparatide (Human recombinant Parathyroid Hormone 1-34) is an anabolic agent that is frequently used in patients with osteoporosis and has been extensively investigated with animal model and clinical studies in current literature. The purpose of the study was to evaluate the impact of teriparatide on bone mineral density and fusion. Materials and methods: The findings from preclinical studies that have investigated the role of teriparatide in animal models are summarized in presented review. Results: Overall, the studies show an improvement in bone mineral density and increased fusion rates for osteoporotic animals undergoing spine fusion with teriparatide use. Conclusion: Further studies should be conducted for unanswered questions, such as teriparatide use before surgery, the effect on cervical fusion and surgery related complications.

KW - Animal model

KW - Bmd

KW - Lumbar fusion

KW - Osteoporosis

KW - Teriparatide

UR - http://www.scopus.com/inward/record.url?scp=85067452372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067452372&partnerID=8YFLogxK

U2 - 10.1080/00207454.2018.1564051

DO - 10.1080/00207454.2018.1564051

M3 - Article

C2 - 30587048

AN - SCOPUS:85067452372

VL - 129

SP - 814

EP - 820

JO - International Journal of Neuroscience

JF - International Journal of Neuroscience

SN - 0020-7454

IS - 8

ER -